Role of Terminal Warm Blood Cardioplegia as Myocardial Protection in the Use of Histidine-Tryptophan-Ketoglutarate Cardioplegia in Complex Congenital Heart Surgery
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 110 participants.
Also called NCT02618824
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 110 participants
- Sponsor
- National Cardiovascular Center Harapan Kita Hospital Indonesia
- Registry
-
NCT02618824
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Indonesia
- Registry status
- Unknown status
Technical summary
Registry record NCT02618824. Randomized; double masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2016-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Role of Terminal Warm Blood Cardioplegia as Myocardial Protection in the Use of Histidine-Tryptophan-Ketoglutarate Cardioplegia in Complex Congenital Heart Surgery
- Condition
- Congenital Heart Disease
- Intervention (Drug)
- Histidine Tryptophan Ketoglutarate Solution
- Intervention (Other)
- Terminal Warm Blood Cardioplegia
- Lead sponsor
- National Cardiovascular Center Harapan Kita Hospital Indonesia
Record details
- Record id
cardio:ct-nct02618824- Content hash
39742f2c6a347f5b7cf3845300749842df508dff0830e139eec6476470992f3c